S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

AGIO Agios Pharmaceuticals Inc

31.84

0.00 (0.00%)

Jan 02 2025 - Closed

Delayed by 15 minutes

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

null

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Agios Pharmaceuticals Charts.

Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Agios Pharmaceuticals Charts.

Agios Pharmaceuticals Inc News

European Commission Adopts Positive Decision for Orphan Medicinal Product Designation of Agios’ Mitapivat in Sickle Cell Disease
Wednesday 18 December 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Friday 13 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Agios Presents Positive Results from Phase 3 ENERGIZE-T Study of Mitapivat at ASH 2024 and Provides Regulatory Update on Mitapivat
Sunday 8 December 2024 (4 weeks ago) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 12 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Thursday 7 November 2024 (2 months ago) • Edgar (US Regulatory)

Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition
Tuesday 5 November 2024 (2 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 31 October 2024 (2 months ago) • Edgar (US Regulatory)

More Agios Pharmaceuticals Inc News Articles

Accredited Solutions (PK)

Quantum eMotion (QB)

TPT Global Tech (CE)

Valiant Eagle (PK)

Fannie Mae (QB)

RespireRx Pharmaceuticals (CE)

Apple Rush (PK)

Anavex Life Sciences

Kraig Biocraft Laborator... (QB)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions